Biontech

Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge

Another 11,671 PCR-confirmed coronavirus cases reported in past few days

Emily O’Reilly criticises executive for not disclosing Von Der Leyen messages

Companies to test fourth dose of current vaccine against fourth dose of new one

Dr Barney Graham’s discovery was a key step in development of Covid-19 vaccines

In lab tests the drug maintained its antiviral activity against all variants of concern

Drugmakers hope to build on success of Covid vaccine

Next year may bring good news but many of the concerns of 2021 will not have gone away

Next phase of vaccination programme in January complicated by multiple rollouts

More than 1.3 million boosters are given in State so far in race against highly contagious Omicron variant

Data shows no need for variant-specific vaccines, says Biden’s chief medical adviser

Registration for ages five to 11 will open shortly, with priority for those more at risk

Israeli research compared blood samples between two-dose group and booster group

Omicron expected to overtake the dominant Delta variant in the UK ‘by mid-December’

US indices rise as inflation report is in line with expectations

Increased restrictions to contain the Omicron coronavirus variant temper optimism

‘Yo-yo day’ prevails on Dublin stock market

Third vaccine dose as effective as second shot was in fighting original virus, study finds

Total global output will be more than 20 billion shots for the year

New coronavirus variant likely to be more transmissible but less severe, Fauci says

Investors not holding back despite ongoing challenges from pandemic

Moderna will be the main vaccine administered over coming weeks to over-60s, over-50s, healthcare workers and younger people in vulnerable groups

The variant has shown that wealthy states will be unable to vaccinate themselves to immunity while large areas remain unvaccinated

Investors will be offside if Omicron does prove to be a game-changer

Von der Leyen comments as signs Germany to join Austria in move towards obligatory jabs

Dutch health ministry finds cases from 10 days ago, before South Africa reported variant

Study backs up need for booster doses to stop people suffering breakthrough infections

Broadening of booster campaign in UK to ‘help extend protection into 2022’

Austria considering lockdown on people who are not vaccinated as cases rise across region

Tablet has potential to avoid nine of 10 hospitalisations with virus, says pharma giant

The longer Boris Johnson’s delays introducing basic mitigation measures, the more likely it is that the UK will be forced to adopt wider restrictions

Pfizer/BioNTech vaccine effectiveness ‘falls to 47% six months after second dose’, according to Lancet study

AstraZeneca, received by tens of millions in Europe, not approved by America’s regulator

Tracking survey shows 13% of 18-34 year-olds refusing to take the jab

Company is looking at potential of technology beyond the coronavirus pandemic

Johnson & Johnson study looks at impact of booster two months after original vaccination

Ryanair, Dalata, Flutter and Glanbia among the gainers in Dublin on Friday

Application will feature children aged between six months and five years

Concerns growing over the efficacy of conventional doses

HSE chief says ‘finishing line of this phase of the vaccination programme is so close now’